Safety Consequences of Off-Label Drugs Used for COVID-19 Nabarun Dasgupta Commentary 05 March 2021 Pages: 399 - 402
ISoP Fellowships: Recognising and Promoting Leaders in Pharmacovigilance Deirdre McCarthy From the ISoP 18 March 2021 Pages: 403 - 404
French Pharmacovigilance Public System and COVID-19 Pandemic Aurélie GrandvuilleminMilou-Daniel Dricithe French Pharmacovigilance Network Current Opinion 28 December 2020 Pages: 405 - 408
Risk Management for the 21st Century: Current Status and Future Needs Rania MouchantafDoris AuthMeredith Y. Smith Leading Article Open access 09 February 2021 Pages: 409 - 419
Provision and Need for Medicine Information in Asia and Africa: A Scoping Review of the Literature Pitchaya NualdaisriSarah A. CorlettJanet Krska Review Article 05 March 2021 Pages: 421 - 437
The DIANA Study: Continued Access to Darunavir/Ritonavir (DRV/r) and Long-Term Safety Follow-Up in HIV-1-Infected Pediatric Patients Aged 3 to < 18 Years Avy ViolariMaysseb MasenyaMagda Opsomer Original Research Article 24 December 2020 Pages: 439 - 446
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015 Yasser AlbogamiAmir SarayaniAlmut G. Winterstein Original Research Article Open access 08 March 2021 Pages: 447 - 454
Evaluation of the Risk of Inflammatory Bowel Disease after the HPV Vaccination in Primary Care in Spain: A Time-Varying Cohort Analysis of Around 390,000 Girls Elisa Martín-MerinoBelén Castillo-CanoDolores Montero-Corominas Original Research Article 19 January 2021 Pages: 455 - 466
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies J. Mark FitzGeraldPaul M. O’ByrneHelen K. Reddel Original Research Article Open access 06 February 2021 Pages: 467 - 478
Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA James WeaverAzza ShoaibiElliot Barnathan Original Research Article Open access 02 March 2021 Pages: 479 - 497
Communicating About Risks and Safe Use of Medicines I. Ralph Edwards Book Review 19 February 2021 Pages: 499 - 501
Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” Robert P. GiuglianoRaffaele De CaterinaTakeshi Yamashita Letter to the Editor Open access 24 February 2021 Pages: 503 - 504
Authors’ Reply to Robert P. Giugliano and Colleagues’ Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” Emanuel RaschiMichele FusaroliElisabetta Poluzzi Letter to the Editor 24 February 2021 Pages: 505 - 506
Correction to: Assessing the Safety of COVID-19 Vaccines: A Primer Helen Petousis-Harris Correction 16 February 2021 Pages: 507 - 507
Correction to: 19th ISoP Annual Meeting “New Opportunities for New Generations” Bogotá, Colombia, 26–29 October, 2019 Correction 20 February 2021 Pages: 509 - 509